Population pharmacokinetic modeling of alemtuzumab in pediatric patients undergoing allogeneic hematopoietic cell transplantation for non-malignant diseases

Tsuyoshi Fukuda

[O27-4-2] Population pharmacokinetic modeling of alemtuzumab in pediatric patients undergoing allogeneic hematopoietic cell transplantation for non-malignant diseases

Tsuyoshi Fukuda¹, Chie Emoto², Rebecca A. Marsh³, Lisa Neumeier⁴, Parinda A. Mehta⁵, Alexander A. Vinks⁶ (1.Cincinnati Children's Hospital Medical Center, 2.Cincinnati Children's Hospital Medical Center, 3.Cincinnati Children's Hospital Medical Center, 4.Cincinnati Children's Hospital Medical Center, 5.Cincinnati Children's Hospital Medical Center, 6.Cincinnati Children's Hospital Medical Center)

キーワード：Alemtuzumab, Monoclonal antibody, Hematopoietic cell transplantation, Pediatric, Population PK

Abstract password authentication.
Password to view abstracts and 'Participants' page is announced on the e-blast sent to early-bird/advanced registrants on September 13. It is also on the page 7 of IATDMCT 2017 PROGRAM BOOK.

講演情報

[O27-4] O27-4: Oncology (2)

[O27-4-2] Population pharmacokinetic modeling of alemtuzumab in pediatric patients undergoing allogeneic hematopoietic cell transplantation for non-malignant diseases

パスワード